|Articles|December 1, 2002

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components
Volume 8
Issue 18 Suppl

Quality of Life and Symptom Measures in Oncology: An Overview

Author(s)Mehul K. Soni, PharmD, David Cella, PhD

Download PDF: Quality of Life and Symptom Measures in Oncology: An Overview

Articles in this issue

about 23 years ago

Article

Participating Faculty

about 23 years ago

Article

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components

about 23 years ago

Article

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

about 23 years ago

Article

Quality-of-Life Measurements: A Soft Outcome - Or is it?

about 23 years ago

Article

The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

about 23 years ago

Article

Continuing Medical Education Quiz

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Subjective and Objective Impacts of Ambulatory AI Scribes

ByJulia Adler-Milstein, PhD,Orianna DeMasi, PhD,Hossein Soleimani, PhD,Sarah Beck, MDiv,Maria E. Byron, MD,Aris Oates, MD,Robert Thombley, BS,Jinoos Yazdany, MD, MPH,Sara G. Murray, MD, MAS

January 8th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Quality of Life and Symptom Measures in Oncology: An Overview

Articles in this issue

Newsletter

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Subjective and Objective Impacts of Ambulatory AI Scribes

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care

Semaglutide Shows Promise for Steatohepatitis Resolution in MASH

Advancing Biomarker Testing Across GU, Lung, and Myeloma Care

RWD Is Transforming Mental Health, Neurology Managed Care: Mitzi Wasik, PharmD

Smart Speaker Improves Mental Health, A1C in Older Adults With Diabetes